NCT00649220View on ClinicalTrials.gov

Memantine and Antipsychotics Use

PHASE4TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

June 30, 2009

Conditions
Alzheimer's Disease
Interventions
DRUG

Memantine

memantine tablets, twice a day (bid), for 20 weeks

Trial Locations (1)

Unknown

Alexianer Hospital, Krefeld

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT00649220 - Memantine and Antipsychotics Use | Biotech Hunter | Biotech Hunter